WuXi AppTec, a leading global pharmaceutical CRDMO, has received Frost & Sullivan's 2026 Global Company of the Year Recognition in the CRDMO industry for the tenth consecutive year. Frost & Sullivan highlighted WuXi AppTec's integrated CRDMO model, which enables the company to support customers across the ful…
Viralgen, a leading contract development and manufacturing organization (CDMO) specializing in adeno-associated virus (AAV) gene therapy manufacturing, a subsidiary of AskBio, Inc. within the Bayer Group, announced that Chief Executive Officer (CEO) Jimmy Vanhove will transition to a new role leading the development a…
Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, appoints Todd Garner as Executive Vice President and Chief Financial Officer, effective September 21, 2026. Garner will oversee the company's global finance organizat…
TETRAPHARM has appointed Rolf Sass Sørensen as Chief Executive Officer, effective 6 October 2026. He succeeds Martin Rose, who founded the company together with Jesper Breum in 2018. The leadership transition comes as TETRAPHARM advances its novel drug molecules and proprietary drug development delivery technologies …
Spark Biomedical, a commercial-stage bioelectronic medicine company pioneering non-invasive multi-path neurostimulation devices, announced the addition of three industry veterans who have guided companies to market success. The new team brings the experience to advance Spark's strategic priorities — developing multi-…
Boston Scientific Corporation announced the appointment of Joseph M. Fitzgerald to executive vice president and chief operating officer (COO), effective Jan. 1, 2027. In this role, Fitzgerald will oversee the company's global operations, business units and regions. In connection with Fitzgerald's appointment, Boston …
HOVIONE HOLDING AG announced the appointment of Stefan Doboczky as Chief Executive Officer (CEO), effective April 1, 2027. Stefan Doboczky has served as Chairman of the Board of Directors of HOVIONE HOLDING AG since 2024, where he has been instrumental in shaping the company’s strategy and vision. He will step down a…
Insmed Incorporated , a people-first global biopharmaceutical company striving to deliver first- and best-in-class therapies to transform the lives of patients facing serious diseases, announced that Sara Bonstein will step down as Chief Financial Officer (CFO). Ms. Bonstein will continue to serve as CFO until October…
BioMarin Pharmaceutical Inc. announced that Cara Bauer, Ph.D., has been named Executive Vice President, Chief People Officer. Ms. Bauer will assume responsibility for the company's Human Resources organization, effective Oct. 5, succeeding Amy Wireman, who is retiring. Ms. Bauer joins BioMarin from Kyverna Therapeuti…
Emerald Clinical Trials, a leading global clinical research organization anchored in Asia-Pacific, announced the appointment of Michael Stibilj as Chief Executive Officer, effective 1 October 2026. The appointment marks the beginning of the company's next phase of growth. "Michael is the right leader for Emerald Clin…
Page 1 of 16